Biktarvy Tablet
Product Images NDC 61958-2501

5 FDA label images from Gilead Sciences, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Biktarvy (NDC 61958-2501). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gilead Sciences, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Biktarvy 01)

Chemical Structure (Biktarvy 01)
Chemical structure of the active ingredient bictegravir sodium, showing the molecular arrangement and key functional groups as depicted in the image.*
FDA Label Image

Chemical Structure (Biktarvy 02)

Chemical Structure (Biktarvy 02)
Chemical structure of the active ingredient in Biktarvy, consisting of bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate. The diagram shows molecular bonds and atom placement relevant to the compound's chemical identity.*
FDA Label Image

Chemical Structure (Biktarvy 03)

Chemical Structure (Biktarvy 03)
Chemical structure diagram showing the molecular components of bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate, the active ingredients in Biktarvy tablets from Gilead Sciences, Inc.*
FDA Label Image

Principal Display Panel (50 mg/200 mg/25 mg Tablet Bottle Label)

Principal Display Panel (50 mg/200 mg/25 mg Tablet Bottle Label)
Biktarvy tablets label showing the product containing 50 mg bictegravir, 200 mg emtricitabine, and 25 mg tenofovir alafenamide per tablet. The label indicates a package of 30 oral tablets, manufactured for Gilead Sciences, Inc., made in Germany. Storage and safety instructions are partially visible, including a warning to keep out of reach of children and a pharmacist note on drug interactions.*
FDA Label Image

Biktarvy 05

Biktarvy 05
Biktarvy tablets containing 30 mg bictegravir, 120 mg emtricitabine, and 15 mg tenofovir alafenamide fumarate. The label shows the product name, active ingredients, strengths, and tablet count of 30. Manufactured for Gilead Sciences, Inc. Storage instructions and warnings to keep out of reach of children are included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.